Abstract
To the Editor. —The article by Dr Willcox and colleagues 1 requires a response. As a geriatrician, I agree that most of the drugs listed should not be prescribed for the elderly. I am struck, however, by the inclusion of amitriptyline, which unquestionably works better for chronic pain syndrome in low doses (10 to 25 mg) than other tricyclic drugs, and in those doses causes little anticholinergic or orthostatic change in the patients of my practice. I was also surprised at the failure to include voltaren, which has a risk of aplastic anemia that is probably comparable with phenylbutazone. I was also struck by the inclusion of propranolol, which in my experience causes few adverse effects (other than bronchospasm) in geriatric doses (20 to 80 mg per day) compared with other β-blockers and has the advantage of a shorter half-life. Data show that β-blockers are the most effective drugs available
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: JAMA: The Journal of the American Medical Association
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.